Children who presented to the ED with severe asthma ... 5 mg/kg intravenous hydrocortisone as a bolus administered over 3 mins immediately followed by an infusion of the study drug administered ...

The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology ...

2, 2025 — A new, non-invasive nasal swab test for kids that diagnoses specific asthma subtype, or endotype, could help clinicians prescribe medications more precisely and pave the way for ...

More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like AstraZeneca’s Fasenra (benralizumab ...

Regulators in the EU, China, and Japan have started reviews of GSK's depemokimab, aiming to become the first drug for severe asthma that can be given just twice a year. The EMA and counterparts in ...

randomized clinical trials to evaluate specific drug interventions on important outcomes such as lung function, acute exacerbations, quality of life and mortality. Asthma is a syndrome consisting ...

A Malaysian woman's holiday in Hokkaido, Japan, took a frightening turn when she contracted influenza and required hospital ...

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.

This medication is injected into a vein as directed by your doctor. The dosage and length of treatment are based on your medical condition and response to treatment. Children's dosage may also be ...

Like other drugs, nicotine affects the brain with the release of dopamine, reinforcing the behavior and leading to addiction. In addition, it contributes to several respiratory diseases including ...

If new lesions do develop, a doctor may switch to a new DMT. Drugs that modify the course of the disease can be injected, taken orally, or infused through the bloodstream using a needle into a vein ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications consumed more than 80% of Medicare Part D spending, researchers reported.